2
Clinical Trials associated with Cellgram-LCInvestigator-initiated Clinical Trial to Evaluate the Safety and Efficacy of Magnetic targeting using Autologous Bone Marrow-derived Mesenchymal Stem Cell (m-MSC) in Knee Osteoarthritis
Start Date20 Oct 2021 |
Sponsor / Collaborator- |
A Multicenter, Randomized, Open-label Phase III Clinical Trial to Evaluate Efficacy and Safety of the Cellgram-LC in Patients With Alcoholic Liver Cirrhosis
This phase III clinical trial is designed to evaluate the efficacy and safety of autologous Mesenchymal Stem Cells (MSC) injected hepatic artery.
100 Clinical Results associated with Cellgram-LC
100 Translational Medicine associated with Cellgram-LC
100 Patents (Medical) associated with Cellgram-LC
100 Deals associated with Cellgram-LC